🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ropinirole Hydrochloride (ROP) was granted approval for the treatment of Pa...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-06
Trial ID
NCT00485069
Treatments Being Tested
The purpose of this study is to obtain information on the long-term safety,...
Status
Completed
Location
GSK Investigational Site
Start Date
2002-05
Trial ID
NCT00650104
Treatments Being Tested
This is an initial placebo-controlled study followed by open treatment eval...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-03
Trial ID
NCT00329602
Treatments Being Tested
To investigate the efficacy and the safety of ropinirole PR/XR tablets to r...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-03
Trial ID
NCT00823836
Treatments Being Tested
This is a multi-center, Phase III study to evaluate the safety and tolerabi...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-11-14
Trial ID
NCT00256854
This is a two-period dose rising study of Ropinirole Immediate Release in a...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-06-10
Trial ID
NCT00140712
Treatments Being Tested
This is a multicenter, placebo controlled, parallel group, double-blind, ra...
Status
Terminated
Location
GSK Investigational Site
Start Date
2009-11-30
Trial ID
NCT00996944
Treatments Being Tested
This study was designed to compare the effectiveness and tolerability of a ...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-06-20
Trial ID
NCT00331149
Treatments Being Tested
To evaluate the safety profile of ropinirole XL during long-term treatment ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-02
Trial ID
NCT00632736
Treatments Being Tested
To determine if there is any difference in the presence of retinal deterior...
Status
Completed
Location
248.538.00007 Boehringer Ingelheim Investigational Site
Start Date
2005-01
Trial ID
NCT00144300